Adjuvant Therapy for Breast Cancer
- 1 February 2000
- journal article
- review article
- Published by Annual Reviews in Annual Review of Medicine
- Vol. 51 (1) , 377-392
- https://doi.org/10.1146/annurev.med.51.1.377
Abstract
Substantial progress has been made in the diagnosis and management of primary breast cancer over the past three decades. As a result, mortality related to this disease has been decreasing gradually for several years, treatment has become more effective, and side effects and complications related to treatment have decreased. In this report, we review the state of adjuvant therapy for breast cancer.Keywords
This publication has 46 references indexed in Scilit:
- Randomised controlled trial of high dose chemotherapy (HD-CNVp) versus standard dose (CAF) chemotherapy for high risk, surgically treated, primary breast cancerEuropean Journal Of Cancer, 1999
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Ovarian ablation in early breast cancer: overview of the randomised trialsThe Lancet, 1996
- Sequential or alternating doxorubicin and CMF regimens in breast cancer with more than three positive nodes. Ten-year resultsPublished by American Medical Association (AMA) ,1995
- Multidisciplinary management of advanced primary and metastatic breast cancerCancer, 1994
- Present Status of Anthracyclines in the Adjuvant Treatment of Breast CancerDrugs, 1993
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Locally Advanced Breast Cancer: A Review Including the M.D. Anderson ExperiencePublished by Springer Nature ,1991
- Systemic chemotherapy as an adjuvant to surgery in the treatment of breast cancerCancer, 1969